There are 749 resources available
208O - Association between kidney function, proteinuria and the risk of kidney cancer: A nationwide cohort study involving 10 million participants
Presenter: Jinsung Park
Session: Mini Oral session - Genitourinary tumours
Resources:
Abstract
209O - A novel risk-based approach simulating oncologic surveillance according to smoking status after radical nephroureterectomy with upper tract urothelial carcinoma
Presenter: Keisuke Shigeta
Session: Mini Oral session - Genitourinary tumours
Resources:
Abstract
Do biosimilars really save cost in practice?
Presenter: Partha Basumatary
Session: Biosimilars use in oncology: Clarifying concepts
Resources:
Slides
Webcast
Precision medicine in cellular therapies: How can we identify patients who would benefit most
Presenter: Alena Gros
Session: Precision immunotherapy
Resources:
Slides
Webcast
New biomarkers for checkpoint inhibitor therapy
Presenter: Jayesh Desai
Session: Precision immunotherapy
Resources:
Slides
Webcast
Localized disease: Retroperitoneal
Presenter: Aisha Miah
Session: The multi-modality approach to sarcomas: Balancing cure and quality of life
Resources:
Slides
Webcast
Locally advanced disease
Presenter: Makoto Endo
Session: The multi-modality approach to sarcomas: Balancing cure and quality of life
Resources:
Slides
Webcast
Multi-focal metastatic
Presenter: Fernando Gracieux Jr.
Session: The multi-modality approach to sarcomas: Balancing cure and quality of life
Resources:
Slides
Webcast
Randomised efficacy and safety results for atezolizumab (Atezo) + bevacizumab (Bev) in patients (pts) with previously untreated, unresectable hepatocellular carcinoma (HCC)
Presenter: Chih-Hung Hsu
Session: Mixed Proffered paper session - Gastrointestinal tumours & Head and neck cancers
Resources:
Slides
Webcast
Invited Discussant LBA7
Presenter: Su Pin Choo
Session: Mixed Proffered paper session - Gastrointestinal tumours & Head and neck cancers
Resources:
Slides
Webcast